Ir Biosciences Holdings Inc (IRBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 0 | N/A | N/A | 220 |
| Other current assets | 0 | 40 | 0 | 0 | 80 |
| TOTAL | $N/A | $40 | $N/A | $N/A | $300 |
| Non-Current Assets | |||||
| PPE Net | N/A | 20 | N/A | N/A | 30 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 7 |
| TOTAL | $N/A | $20 | $N/A | $N/A | $37 |
| Total Assets | $N/A | $60 | $N/A | $N/A | $350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 2,560 | 0 | 0 | 930 |
| Other current liabilities | N/A | 300 | N/A | N/A | 0 |
| TOTAL | $N/A | $6,500 | $N/A | $N/A | $930 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 890 | 0 | 0 | 0 |
| TOTAL | $N/A | $890 | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $7,400 | $N/A | $N/A | $930 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 10 | N/A | N/A | 110 |
| Retained earnings | N/A | -33,030 | N/A | N/A | -18,740 |
| Other shareholders' equity | 0 | 5,980 | 0 | 0 | 150 |
| TOTAL | $N/A | $-7,330 | $N/A | $N/A | $-580 |
| Total Liabilities And Equity | $0 | $70 | $0 | $0 | $350 |